STRIDE: Phase III study of therapeutic cancer vaccine L-BLP25 with hormonal treatment as first-line therapy for women with hormone receptor-positive, inoperable, locally advanced, recurrent, or metastatic breast cancer Meeting Abstract


Authors: Eiermann, W.; Miles, D.; Gilewski, T.; Trudeau, M.; Xu, B.; Barrios, C.; Pendergrass, K.; Eggleton, S. P.; Kashala, O.; Shulman, L.
Abstract Title: STRIDE: Phase III study of therapeutic cancer vaccine L-BLP25 with hormonal treatment as first-line therapy for women with hormone receptor-positive, inoperable, locally advanced, recurrent, or metastatic breast cancer
Meeting Title: 7th European Breast Cancer Conference (EBCC 7)
Journal Title: EJC Supplements
Volume: 8
Issue: 3
Meeting Dates: 2010 Mar 24-27
Meeting Location: Barcelona, Spain
ISSN: 1359-6349
Publisher: Pergamon-Elsevier Science Ltd  
Date Published: 2010-03-01
Start Page: 87
End Page: 88
Language: English
ACCESSION: ISI:000276756900129
PROVIDER: wos
DOI: 10.1016/S1359-6349(10)70132-4
Notes: --- - Meeting Abstract: 101 - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors